初级保健中的痴呆症和并发症:一个范围审查
Howard Bergman1, Soo Borson2, Frank Jessen3
1Department of Family Medicine, McGill University, 5858 Ch. de La Côte-Des-Neiges, Suite 300, Montreal, QC, H3S 1Z1, Canada. howard.bergman@mcgill.ca.
BMC primary care
|December 15, 2023
概括
初级保健提供者 (PCP) 面临着管理痴呆与并发症的挑战. 本次审查强调了PCP需要更好的工具和指导,以改善多种慢性疾病患者的痴呆症护理.
科学领域:
- 老年学是一门学科.
- 主要护理医学 医疗保健
- 神经学 神经学
背景情况:
- 痴呆症 (PwD) 患者通常有多种慢性疾病,使护理复杂化并降低生活质量.
- 初级保健提供者 (PCP) 对于痴呆症护理至关重要,但他们对伴随疾病的做法的适应尚不清楚.
研究的目的:
- 绘制最近关于PCP在痴呆症预防,检测和管理以及伴随疾病中的作用的文献.
- 识别知识缺口,并建议该领域的未来研究方向.
主要方法:
- 进行了2017-2022年同行评审文献的范围审查.
- 搜索包括MEDLINE,Cochrane图书馆和Scopus使用痴呆症,初级保健和并发症的术语.
- 相关文章被分类为"风险评估和预防"",查,检测和诊断"或"管理".
主要成果:
- 在1,058个记录中,包括了28篇文章. 大约50%的研究集中在使用先前存在的疾病评估痴呆风险的工具上.
- 只有一个出版物为管理伴随疾病患者的PCP提供了官方痴呆症查指南.
- 大约30%的文章涉及管理痴呆症护理,强调多学科模式,减少不适当的处方.
结论:
- 这是关于PCP在伴随疾病的痴呆症护理中的作用的首次范围审查.
- 未来的研究应该验证风险评估工具,为痴呆症护理中的伴随性疾病管理提供指导,并将伴随性疾病纳入痴呆症初级保健质量指标中.
相关概念视频
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Documentation in Long-Term and Home Healthcare Setting
893
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
893
Factors Affecting Illness
4.2K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.2K
Methods of Documentation VI: Case Management Model
574
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
574
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195


